Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

A method to quantitatively detect H-ras point mutation based on electrochemiluminescence.

Debin Zhu1, Da Xing, Xingyan Shen

  • 1Institute of Laser Life Science, South China Normal University, Guangzhou 510631, China. xingda@scnu.edu.cn

Biochemical and Biophysical Research Communications
|October 12, 2004
PubMed
Summary

This study presents a novel, safe, and sensitive method for detecting H-ras point mutations in bladder cancer. The developed assay accurately quantifies mutations, identifying them in nearly half of the analyzed samples.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Critical factors influencing the adoption of virtual reality technology for improving mental health among university students: an extended technology acceptance model.

Frontiers in psychology·2026
Same author

Enhanced solidification/stabilization (S/S) of fluoride in smelting solid waste-based phosphogypsum cemented paste backfill utilizing biochar: Mechanisms and performance assessment.

Journal of environmental management·2024
Same author

Specific disruption of glutathione-defense system with activatable single molecule-assembled nanoprodrug for boosted photodynamic/chemotherapy eradication of drug-resistant tumors.

Biomaterials·2022
Same author

Promoted CD4<sup>+</sup> T cell-derived IFN-γ/IL-10 by photobiomodulation therapy modulates neurogenesis to ameliorate cognitive deficits in APP/PS1 and 3xTg-AD mice.

Journal of neuroinflammation·2022
Same author

Controlling dielectric loss of biodegradable black phosphorus nanosheets by iron-ion-modification for imaging-guided microwave thermoacoustic therapy.

Biomaterials·2022
Same author

Portable Microwave-Acoustic Coaxial Thermoacoustic Probe With Miniaturized Vivaldi Antennas for Breast Tumor Screening.

IEEE transactions on bio-medical engineering·2022

Area of Science:

  • Molecular Biology
  • Oncology
  • Biochemistry

Background:

  • Conventional point mutation detection methods are often complex, hazardous, and provide only semi-quantitative results.
  • Accurate and sensitive detection of oncogene mutations is crucial for cancer diagnosis and treatment.

Purpose of the Study:

  • To develop a quantitative, safe, and sensitive protocol for detecting point mutations in the H-ras oncogene.
  • To apply this method to analyze H-ras mutations in bladder cancer patient samples.

Main Methods:

  • Developed a quantitative detection protocol by coupling Electrochemiluminescence (ECL) assay with restriction endonuclease digestion directly from PCR products.
  • Utilized the principle that only wild-type amplicons are cleaved, preventing their detection by ECL.

Related Experiment Videos

  • Analyzed 30 bladder cancer samples for point mutations at codon 12 of the H-ras oncogene using the PCR-ECL method.

    • Main Results:

    • The PCR-ECL method demonstrated a detection limit of 100 fmol for H-ras amplicon with a linear range exceeding three orders of magnitude.
    • Point mutations in the H-ras oncogene were identified in 14 out of 30 (46.7%) bladder cancer samples.
    • The assay proved to be highly sensitive and quantitative.

    Conclusions:

    • The developed PCR-ECL method is a feasible and effective quantitative approach for point mutation detection.
    • This method offers advantages in safety, high sensitivity, and simplicity compared to conventional techniques.
    • The findings highlight the prevalence of H-ras point mutations in bladder cancer, underscoring the utility of this novel detection assay.